nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—breast cancer—colon cancer	0.283	0.554	CtDrD
Tamoxifen—pancreatic cancer—colon cancer	0.227	0.446	CtDrD
Tamoxifen—ABCB1—colon cancer	0.0804	1	CbGaD
Tamoxifen—CES1—Capecitabine—colon cancer	0.0631	0.227	CbGbCtD
Tamoxifen—CES1—Irinotecan—colon cancer	0.039	0.14	CbGbCtD
Tamoxifen—ABCB11—Vincristine—colon cancer	0.0196	0.0704	CbGbCtD
Tamoxifen—ABCC2—Irinotecan—colon cancer	0.0118	0.0423	CbGbCtD
Tamoxifen—CYP2A6—Fluorouracil—colon cancer	0.011	0.0397	CbGbCtD
Tamoxifen—ABCG2—Irinotecan—colon cancer	0.0107	0.0383	CbGbCtD
Tamoxifen—ABCC2—Vincristine—colon cancer	0.0103	0.037	CbGbCtD
Tamoxifen—ABCG2—Fluorouracil—colon cancer	0.0102	0.0367	CbGbCtD
Tamoxifen—ABCG2—Vincristine—colon cancer	0.00931	0.0335	CbGbCtD
Tamoxifen—CYP3A7—Irinotecan—colon cancer	0.00787	0.0283	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.00787	0.0283	CbGbCtD
Tamoxifen—CYP2B6—Irinotecan—colon cancer	0.00749	0.0269	CbGbCtD
Tamoxifen—CYP3A7—Vincristine—colon cancer	0.00688	0.0247	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.00688	0.0247	CbGbCtD
Tamoxifen—CYP2C9—Capecitabine—colon cancer	0.00641	0.023	CbGbCtD
Tamoxifen—ABCC2—Methotrexate—colon cancer	0.00624	0.0224	CbGbCtD
Tamoxifen—CYP3A5—Irinotecan—colon cancer	0.0059	0.0212	CbGbCtD
Tamoxifen—ABCG2—Methotrexate—colon cancer	0.00564	0.0203	CbGbCtD
Tamoxifen—CYP2C8—Fluorouracil—colon cancer	0.00545	0.0196	CbGbCtD
Tamoxifen—CYP3A5—Vincristine—colon cancer	0.00516	0.0185	CbGbCtD
Tamoxifen—CYP1A2—Fluorouracil—colon cancer	0.00422	0.0151	CbGbCtD
Tamoxifen—ABCB1—Irinotecan—colon cancer	0.00384	0.0138	CbGbCtD
Tamoxifen—CYP2C9—Fluorouracil—colon cancer	0.0038	0.0136	CbGbCtD
Tamoxifen—ABCB11—bile—colon cancer	0.00336	0.0978	CbGeAlD
Tamoxifen—ABCB1—Vincristine—colon cancer	0.00336	0.0121	CbGbCtD
Tamoxifen—CYP3A4—Irinotecan—colon cancer	0.0023	0.00827	CbGbCtD
Tamoxifen—ABCB1—Methotrexate—colon cancer	0.00203	0.0073	CbGbCtD
Tamoxifen—CYP3A4—Vincristine—colon cancer	0.00201	0.00723	CbGbCtD
Tamoxifen—ABCC2—bile—colon cancer	0.00171	0.0497	CbGeAlD
Tamoxifen—EBPL—epithelium—colon cancer	0.000978	0.0284	CbGeAlD
Tamoxifen—CES1—gall bladder—colon cancer	0.000729	0.0212	CbGeAlD
Tamoxifen—SULT1A1—renal system—colon cancer	0.00072	0.021	CbGeAlD
Tamoxifen—UGT1A4—renal system—colon cancer	0.000629	0.0183	CbGeAlD
Tamoxifen—SULT1A1—digestive system—colon cancer	0.000591	0.0172	CbGeAlD
Tamoxifen—EBPL—liver—colon cancer	0.000554	0.0161	CbGeAlD
Tamoxifen—EBP—liver—colon cancer	0.000531	0.0155	CbGeAlD
Tamoxifen—SULT1A1—vagina—colon cancer	0.000522	0.0152	CbGeAlD
Tamoxifen—UGT1A4—digestive system—colon cancer	0.000516	0.015	CbGeAlD
Tamoxifen—FMO1—renal system—colon cancer	0.000512	0.0149	CbGeAlD
Tamoxifen—ESRRA—renal system—colon cancer	0.000504	0.0147	CbGeAlD
Tamoxifen—ESR1—blood vessel—colon cancer	0.000459	0.0134	CbGeAlD
Tamoxifen—SULT1A1—liver—colon cancer	0.00044	0.0128	CbGeAlD
Tamoxifen—DHCR7—lymphoid tissue—colon cancer	0.000425	0.0124	CbGeAlD
Tamoxifen—EBPL—lymph node—colon cancer	0.000425	0.0124	CbGeAlD
Tamoxifen—DHCR7—digestive system—colon cancer	0.00042	0.0122	CbGeAlD
Tamoxifen—FMO1—digestive system—colon cancer	0.00042	0.0122	CbGeAlD
Tamoxifen—ESRRA—digestive system—colon cancer	0.000414	0.012	CbGeAlD
Tamoxifen—DHCR7—bone marrow—colon cancer	0.000387	0.0113	CbGeAlD
Tamoxifen—UGT1A4—liver—colon cancer	0.000384	0.0112	CbGeAlD
Tamoxifen—ESRRA—bone marrow—colon cancer	0.000381	0.0111	CbGeAlD
Tamoxifen—DHCR7—vagina—colon cancer	0.000371	0.0108	CbGeAlD
Tamoxifen—FMO1—vagina—colon cancer	0.000371	0.0108	CbGeAlD
Tamoxifen—ABCB11—digestive system—colon cancer	0.000367	0.0107	CbGeAlD
Tamoxifen—ESRRA—vagina—colon cancer	0.000365	0.0106	CbGeAlD
Tamoxifen—SULT1A1—lymph node—colon cancer	0.000338	0.00982	CbGeAlD
Tamoxifen—ESR2—epithelium—colon cancer	0.000326	0.00949	CbGeAlD
Tamoxifen—FMO3—vagina—colon cancer	0.000321	0.00933	CbGeAlD
Tamoxifen—ESR2—smooth muscle tissue—colon cancer	0.000315	0.00915	CbGeAlD
Tamoxifen—DHCR7—liver—colon cancer	0.000313	0.00911	CbGeAlD
Tamoxifen—FMO1—liver—colon cancer	0.000313	0.00911	CbGeAlD
Tamoxifen—ESRRA—liver—colon cancer	0.000308	0.00897	CbGeAlD
Tamoxifen—ESR2—renal system—colon cancer	0.000303	0.00881	CbGeAlD
Tamoxifen—CES1—lymphoid tissue—colon cancer	0.00029	0.00844	CbGeAlD
Tamoxifen—CES1—digestive system—colon cancer	0.000287	0.00834	CbGeAlD
Tamoxifen—ESR1—embryo—colon cancer	0.000274	0.00797	CbGeAlD
Tamoxifen—ABCB11—liver—colon cancer	0.000274	0.00796	CbGeAlD
Tamoxifen—FMO3—liver—colon cancer	0.000271	0.00787	CbGeAlD
Tamoxifen—CYP3A7—liver—colon cancer	0.000268	0.00779	CbGeAlD
Tamoxifen—ESR2—lymphoid tissue—colon cancer	0.000251	0.00731	CbGeAlD
Tamoxifen—ESR2—digestive system—colon cancer	0.000248	0.00722	CbGeAlD
Tamoxifen—SIGMAR1—smooth muscle tissue—colon cancer	0.000244	0.00709	CbGeAlD
Tamoxifen—DHCR7—lymph node—colon cancer	0.00024	0.00698	CbGeAlD
Tamoxifen—FMO1—lymph node—colon cancer	0.00024	0.00698	CbGeAlD
Tamoxifen—ESRRA—lymph node—colon cancer	0.000236	0.00687	CbGeAlD
Tamoxifen—CYP1B1—smooth muscle tissue—colon cancer	0.000232	0.00674	CbGeAlD
Tamoxifen—ABCC2—renal system—colon cancer	0.000228	0.00662	CbGeAlD
Tamoxifen—CYP3A7-CYP3A51P—liver—colon cancer	0.000228	0.00662	CbGeAlD
Tamoxifen—ESR1—epithelium—colon cancer	0.000224	0.0065	CbGeAlD
Tamoxifen—CYP1B1—renal system—colon cancer	0.000223	0.00649	CbGeAlD
Tamoxifen—CYP2A6—vagina—colon cancer	0.00022	0.00641	CbGeAlD
Tamoxifen—ESR2—vagina—colon cancer	0.000219	0.00638	CbGeAlD
Tamoxifen—ESR1—smooth muscle tissue—colon cancer	0.000215	0.00627	CbGeAlD
Tamoxifen—CES1—liver—colon cancer	0.000214	0.00621	CbGeAlD
Tamoxifen—FMO3—lymph node—colon cancer	0.000207	0.00603	CbGeAlD
Tamoxifen—ESR1—renal system—colon cancer	0.000207	0.00603	CbGeAlD
Tamoxifen—ABCC2—digestive system—colon cancer	0.000187	0.00543	CbGeAlD
Tamoxifen—CYP2A6—liver—colon cancer	0.000186	0.00541	CbGeAlD
Tamoxifen—CYP1B1—lymphoid tissue—colon cancer	0.000185	0.00539	CbGeAlD
Tamoxifen—ESR2—liver—colon cancer	0.000185	0.00538	CbGeAlD
Tamoxifen—CYP1B1—digestive system—colon cancer	0.000183	0.00532	CbGeAlD
Tamoxifen—ABCB1—blood vessel—colon cancer	0.000181	0.00528	CbGeAlD
Tamoxifen—SIGMAR1—bone marrow—colon cancer	0.000177	0.00516	CbGeAlD
Tamoxifen—ESR1—lymphoid tissue—colon cancer	0.000172	0.00501	CbGeAlD
Tamoxifen—CYP2C8—renal system—colon cancer	0.000171	0.00497	CbGeAlD
Tamoxifen—ESR1—digestive system—colon cancer	0.00017	0.00495	CbGeAlD
Tamoxifen—CYP1A1—epithelium—colon cancer	0.00017	0.00494	CbGeAlD
Tamoxifen—SIGMAR1—vagina—colon cancer	0.00017	0.00494	CbGeAlD
Tamoxifen—CES1—lymph node—colon cancer	0.000164	0.00476	CbGeAlD
Tamoxifen—CYP2C19—digestive system—colon cancer	0.000161	0.00467	CbGeAlD
Tamoxifen—CYP1A2—renal system—colon cancer	0.00016	0.00465	CbGeAlD
Tamoxifen—CYP1A1—renal system—colon cancer	0.000158	0.00459	CbGeAlD
Tamoxifen—CYP3A5—renal system—colon cancer	0.000154	0.00448	CbGeAlD
Tamoxifen—CYP2B6—renal system—colon cancer	0.000153	0.00446	CbGeAlD
Tamoxifen—ESR1—vagina—colon cancer	0.00015	0.00437	CbGeAlD
Tamoxifen—CYP19A1—liver—colon cancer	0.000146	0.00424	CbGeAlD
Tamoxifen—CYP2E1—renal system—colon cancer	0.000144	0.00418	CbGeAlD
Tamoxifen—SIGMAR1—liver—colon cancer	0.000143	0.00417	CbGeAlD
Tamoxifen—ESR2—lymph node—colon cancer	0.000142	0.00413	CbGeAlD
Tamoxifen—CYP2C19—vagina—colon cancer	0.000142	0.00412	CbGeAlD
Tamoxifen—ABCC2—liver—colon cancer	0.000139	0.00405	CbGeAlD
Tamoxifen—CYP1B1—liver—colon cancer	0.000136	0.00396	CbGeAlD
Tamoxifen—CYP1A2—digestive system—colon cancer	0.000131	0.00381	CbGeAlD
Tamoxifen—Myocardial infarction—Fluorouracil—colon cancer	0.000129	0.002	CcSEcCtD
Tamoxifen—CYP1A1—digestive system—colon cancer	0.000129	0.00376	CbGeAlD
Tamoxifen—Urinary tract infection—Fluorouracil—colon cancer	0.000128	0.00198	CcSEcCtD
Tamoxifen—Hot flush—Capecitabine—colon cancer	0.000128	0.00198	CcSEcCtD
Tamoxifen—CYP2B6—lymphoid tissue—colon cancer	0.000127	0.0037	CbGeAlD
Tamoxifen—Menopausal symptoms—Capecitabine—colon cancer	0.000127	0.00196	CcSEcCtD
Tamoxifen—ESR1—liver—colon cancer	0.000127	0.00369	CbGeAlD
Tamoxifen—Inflammation—Methotrexate—colon cancer	0.000127	0.00195	CcSEcCtD
Tamoxifen—CYP3A5—digestive system—colon cancer	0.000126	0.00368	CbGeAlD
Tamoxifen—Hypoaesthesia—Vincristine—colon cancer	0.000126	0.00195	CcSEcCtD
Tamoxifen—Thirst—Capecitabine—colon cancer	0.000126	0.00194	CcSEcCtD
Tamoxifen—Vasculitis—Methotrexate—colon cancer	0.000126	0.00194	CcSEcCtD
Tamoxifen—CYP2B6—digestive system—colon cancer	0.000126	0.00366	CbGeAlD
Tamoxifen—ABCG2—bone marrow—colon cancer	0.000126	0.00365	CbGeAlD
Tamoxifen—Dermatitis bullous—Capecitabine—colon cancer	0.000125	0.00193	CcSEcCtD
Tamoxifen—CYP2C9—digestive system—colon cancer	0.000124	0.00362	CbGeAlD
Tamoxifen—Haemoglobin—Irinotecan—colon cancer	0.000124	0.00192	CcSEcCtD
Tamoxifen—Sinusitis—Fluorouracil—colon cancer	0.000124	0.00191	CcSEcCtD
Tamoxifen—Haemorrhage—Irinotecan—colon cancer	0.000124	0.00191	CcSEcCtD
Tamoxifen—CYP2C8—vagina—colon cancer	0.000124	0.0036	CbGeAlD
Tamoxifen—Arthritis—Capecitabine—colon cancer	0.000123	0.0019	CcSEcCtD
Tamoxifen—Vaginal inflammation—Methotrexate—colon cancer	0.000123	0.00189	CcSEcCtD
Tamoxifen—Pulmonary embolism—Methotrexate—colon cancer	0.000123	0.00189	CcSEcCtD
Tamoxifen—ABCG2—vagina—colon cancer	0.00012	0.0035	CbGeAlD
Tamoxifen—Osteoarthritis—Capecitabine—colon cancer	0.00012	0.00185	CcSEcCtD
Tamoxifen—CYP2C19—liver—colon cancer	0.00012	0.00348	CbGeAlD
Tamoxifen—CYP2E1—lymphoid tissue—colon cancer	0.000119	0.00347	CbGeAlD
Tamoxifen—Visual impairment—Irinotecan—colon cancer	0.000119	0.00184	CcSEcCtD
Tamoxifen—Haemoglobin—Fluorouracil—colon cancer	0.000119	0.00184	CcSEcCtD
Tamoxifen—Haemorrhage—Fluorouracil—colon cancer	0.000119	0.00183	CcSEcCtD
Tamoxifen—Hypoaesthesia—Fluorouracil—colon cancer	0.000118	0.00182	CcSEcCtD
Tamoxifen—CYP2E1—digestive system—colon cancer	0.000118	0.00343	CbGeAlD
Tamoxifen—Pharyngitis—Fluorouracil—colon cancer	0.000118	0.00182	CcSEcCtD
Tamoxifen—Skin exfoliation—Methotrexate—colon cancer	0.000117	0.00181	CcSEcCtD
Tamoxifen—Vaginal infection—Methotrexate—colon cancer	0.000116	0.00179	CcSEcCtD
Tamoxifen—CYP3A4—renal system—colon cancer	0.000116	0.00337	CbGeAlD
Tamoxifen—Flushing—Irinotecan—colon cancer	0.000115	0.00177	CcSEcCtD
Tamoxifen—CYP1A1—vagina—colon cancer	0.000114	0.00332	CbGeAlD
Tamoxifen—CYP2D6—renal system—colon cancer	0.000114	0.00331	CbGeAlD
Tamoxifen—Mood swings—Capecitabine—colon cancer	0.000113	0.00175	CcSEcCtD
Tamoxifen—Alopecia—Vincristine—colon cancer	0.000112	0.00173	CcSEcCtD
Tamoxifen—Blood creatinine increased—Capecitabine—colon cancer	0.000112	0.00173	CcSEcCtD
Tamoxifen—CYP19A1—lymph node—colon cancer	0.000112	0.00325	CbGeAlD
Tamoxifen—CYP3A5—vagina—colon cancer	0.000112	0.00325	CbGeAlD
Tamoxifen—Neoplasm—Methotrexate—colon cancer	0.000111	0.00171	CcSEcCtD
Tamoxifen—CYP2B6—vagina—colon cancer	0.000111	0.00323	CbGeAlD
Tamoxifen—Arrhythmia—Irinotecan—colon cancer	0.000111	0.00171	CcSEcCtD
Tamoxifen—Liver function test abnormal—Capecitabine—colon cancer	0.000111	0.00171	CcSEcCtD
Tamoxifen—SIGMAR1—lymph node—colon cancer	0.00011	0.0032	CbGeAlD
Tamoxifen—Alopecia—Irinotecan—colon cancer	0.000109	0.00169	CcSEcCtD
Tamoxifen—Diethylstilbestrol—ABCB1—colon cancer	0.000109	0.309	CrCbGaD
Tamoxifen—ABCB1—embryo—colon cancer	0.000108	0.00315	CbGeAlD
Tamoxifen—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000108	0.00166	CcSEcCtD
Tamoxifen—Back pain—Vincristine—colon cancer	0.000107	0.00165	CcSEcCtD
Tamoxifen—ABCC2—lymph node—colon cancer	0.000107	0.0031	CbGeAlD
Tamoxifen—Sepsis—Methotrexate—colon cancer	0.000107	0.00164	CcSEcCtD
Tamoxifen—Arrhythmia—Fluorouracil—colon cancer	0.000106	0.00163	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000106	0.00163	CcSEcCtD
Tamoxifen—Alopecia—Fluorouracil—colon cancer	0.000105	0.00162	CcSEcCtD
Tamoxifen—CYP1B1—lymph node—colon cancer	0.000104	0.00304	CbGeAlD
Tamoxifen—CYP2C8—liver—colon cancer	0.000104	0.00304	CbGeAlD
Tamoxifen—Back pain—Irinotecan—colon cancer	0.000104	0.00161	CcSEcCtD
Tamoxifen—Muscle spasms—Irinotecan—colon cancer	0.000104	0.0016	CcSEcCtD
Tamoxifen—Influenza—Capecitabine—colon cancer	0.000103	0.0016	CcSEcCtD
Tamoxifen—Dysphagia—Capecitabine—colon cancer	0.000103	0.0016	CcSEcCtD
Tamoxifen—Erythema—Fluorouracil—colon cancer	0.000103	0.00159	CcSEcCtD
Tamoxifen—Anaemia—Vincristine—colon cancer	0.000102	0.00158	CcSEcCtD
Tamoxifen—ABCG2—liver—colon cancer	0.000101	0.00295	CbGeAlD
Tamoxifen—Angina pectoris—Capecitabine—colon cancer	0.000101	0.00156	CcSEcCtD
Tamoxifen—Anaemia—Irinotecan—colon cancer	9.96e-05	0.00154	CcSEcCtD
Tamoxifen—Bronchitis—Capecitabine—colon cancer	9.95e-05	0.00154	CcSEcCtD
Tamoxifen—Abdominal discomfort—Capecitabine—colon cancer	9.92e-05	0.00153	CcSEcCtD
Tamoxifen—Hepatic failure—Methotrexate—colon cancer	9.92e-05	0.00153	CcSEcCtD
Tamoxifen—Leukopenia—Vincristine—colon cancer	9.9e-05	0.00153	CcSEcCtD
Tamoxifen—Pancytopenia—Capecitabine—colon cancer	9.83e-05	0.00152	CcSEcCtD
Tamoxifen—CYP1A2—liver—colon cancer	9.77e-05	0.00284	CbGeAlD
Tamoxifen—ESR1—lymph node—colon cancer	9.71e-05	0.00283	CbGeAlD
Tamoxifen—Neutropenia—Capecitabine—colon cancer	9.68e-05	0.00149	CcSEcCtD
Tamoxifen—Leukopenia—Irinotecan—colon cancer	9.64e-05	0.00149	CcSEcCtD
Tamoxifen—CYP1A1—liver—colon cancer	9.63e-05	0.0028	CbGeAlD
Tamoxifen—Hypertension—Vincristine—colon cancer	9.55e-05	0.00147	CcSEcCtD
Tamoxifen—Anaemia—Fluorouracil—colon cancer	9.54e-05	0.00147	CcSEcCtD
Tamoxifen—CYP3A4—digestive system—colon cancer	9.49e-05	0.00276	CbGeAlD
Tamoxifen—CYP3A5—liver—colon cancer	9.42e-05	0.00274	CbGeAlD
Tamoxifen—Myalgia—Vincristine—colon cancer	9.42e-05	0.00145	CcSEcCtD
Tamoxifen—Weight increased—Capecitabine—colon cancer	9.42e-05	0.00145	CcSEcCtD
Tamoxifen—Visual disturbance—Methotrexate—colon cancer	9.41e-05	0.00145	CcSEcCtD
Tamoxifen—Cough—Irinotecan—colon cancer	9.4e-05	0.00145	CcSEcCtD
Tamoxifen—Weight decreased—Capecitabine—colon cancer	9.36e-05	0.00144	CcSEcCtD
Tamoxifen—CYP2B6—liver—colon cancer	9.36e-05	0.00272	CbGeAlD
Tamoxifen—CYP2D6—digestive system—colon cancer	9.34e-05	0.00272	CbGeAlD
Tamoxifen—Hypertension—Irinotecan—colon cancer	9.3e-05	0.00144	CcSEcCtD
Tamoxifen—Pneumonia—Capecitabine—colon cancer	9.28e-05	0.00143	CcSEcCtD
Tamoxifen—CYP2C9—liver—colon cancer	9.27e-05	0.0027	CbGeAlD
Tamoxifen—Leukopenia—Fluorouracil—colon cancer	9.24e-05	0.00143	CcSEcCtD
Tamoxifen—Depression—Capecitabine—colon cancer	9.2e-05	0.00142	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Capecitabine—colon cancer	9.15e-05	0.00141	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Capecitabine—colon cancer	9.1e-05	0.0014	CcSEcCtD
Tamoxifen—Discomfort—Irinotecan—colon cancer	9.06e-05	0.0014	CcSEcCtD
Tamoxifen—Myocardial infarction—Capecitabine—colon cancer	9.05e-05	0.0014	CcSEcCtD
Tamoxifen—Oedema—Vincristine—colon cancer	9.03e-05	0.00139	CcSEcCtD
Tamoxifen—Infection—Vincristine—colon cancer	8.97e-05	0.00138	CcSEcCtD
Tamoxifen—Urinary tract infection—Capecitabine—colon cancer	8.97e-05	0.00138	CcSEcCtD
Tamoxifen—Osteoarthritis—Methotrexate—colon cancer	8.91e-05	0.00138	CcSEcCtD
Tamoxifen—Thrombocytopenia—Vincristine—colon cancer	8.84e-05	0.00136	CcSEcCtD
Tamoxifen—ABCB1—epithelium—colon cancer	8.83e-05	0.00257	CbGeAlD
Tamoxifen—Oedema—Irinotecan—colon cancer	8.79e-05	0.00136	CcSEcCtD
Tamoxifen—CYP2E1—liver—colon cancer	8.79e-05	0.00256	CbGeAlD
Tamoxifen—Chest pain—Fluorouracil—colon cancer	8.79e-05	0.00136	CcSEcCtD
Tamoxifen—Myalgia—Fluorouracil—colon cancer	8.79e-05	0.00136	CcSEcCtD
Tamoxifen—Infection—Irinotecan—colon cancer	8.74e-05	0.00135	CcSEcCtD
Tamoxifen—Hyperhidrosis—Vincristine—colon cancer	8.73e-05	0.00135	CcSEcCtD
Tamoxifen—Discomfort—Fluorouracil—colon cancer	8.68e-05	0.00134	CcSEcCtD
Tamoxifen—Toremifene—ABCB1—colon cancer	8.64e-05	0.245	CrCbGaD
Tamoxifen—Thrombocytopenia—Irinotecan—colon cancer	8.61e-05	0.00133	CcSEcCtD
Tamoxifen—Anorexia—Vincristine—colon cancer	8.61e-05	0.00133	CcSEcCtD
Tamoxifen—Hyperhidrosis—Irinotecan—colon cancer	8.5e-05	0.00131	CcSEcCtD
Tamoxifen—Mood swings—Methotrexate—colon cancer	8.44e-05	0.0013	CcSEcCtD
Tamoxifen—Oedema—Fluorouracil—colon cancer	8.42e-05	0.0013	CcSEcCtD
Tamoxifen—Anorexia—Irinotecan—colon cancer	8.38e-05	0.00129	CcSEcCtD
Tamoxifen—Infection—Fluorouracil—colon cancer	8.37e-05	0.00129	CcSEcCtD
Tamoxifen—Haemoglobin—Capecitabine—colon cancer	8.33e-05	0.00128	CcSEcCtD
Tamoxifen—Hepatitis—Capecitabine—colon cancer	8.28e-05	0.00128	CcSEcCtD
Tamoxifen—Haemorrhage—Capecitabine—colon cancer	8.28e-05	0.00128	CcSEcCtD
Tamoxifen—Thrombocytopenia—Fluorouracil—colon cancer	8.25e-05	0.00127	CcSEcCtD
Tamoxifen—Hypoaesthesia—Capecitabine—colon cancer	8.24e-05	0.00127	CcSEcCtD
Tamoxifen—Liver function test abnormal—Methotrexate—colon cancer	8.23e-05	0.00127	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Vincristine—colon cancer	8.23e-05	0.00127	CcSEcCtD
Tamoxifen—Pharyngitis—Capecitabine—colon cancer	8.22e-05	0.00127	CcSEcCtD
Tamoxifen—ABCB1—renal system—colon cancer	8.19e-05	0.00238	CbGeAlD
Tamoxifen—Insomnia—Vincristine—colon cancer	8.17e-05	0.00126	CcSEcCtD
Tamoxifen—Oedema peripheral—Capecitabine—colon cancer	8.16e-05	0.00126	CcSEcCtD
Tamoxifen—Paraesthesia—Vincristine—colon cancer	8.11e-05	0.00125	CcSEcCtD
Tamoxifen—Anorexia—Fluorouracil—colon cancer	8.03e-05	0.00124	CcSEcCtD
Tamoxifen—Visual impairment—Capecitabine—colon cancer	7.98e-05	0.00123	CcSEcCtD
Tamoxifen—Insomnia—Irinotecan—colon cancer	7.95e-05	0.00123	CcSEcCtD
Tamoxifen—Paraesthesia—Irinotecan—colon cancer	7.9e-05	0.00122	CcSEcCtD
Tamoxifen—Decreased appetite—Vincristine—colon cancer	7.85e-05	0.00121	CcSEcCtD
Tamoxifen—Dyspnoea—Irinotecan—colon cancer	7.84e-05	0.00121	CcSEcCtD
Tamoxifen—Erythema multiforme—Capecitabine—colon cancer	7.83e-05	0.00121	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Vincristine—colon cancer	7.8e-05	0.0012	CcSEcCtD
Tamoxifen—Fatigue—Vincristine—colon cancer	7.78e-05	0.0012	CcSEcCtD
Tamoxifen—ABCG2—lymph node—colon cancer	7.78e-05	0.00226	CbGeAlD
Tamoxifen—Dyspepsia—Irinotecan—colon cancer	7.74e-05	0.00119	CcSEcCtD
Tamoxifen—Pain—Vincristine—colon cancer	7.72e-05	0.00119	CcSEcCtD
Tamoxifen—Constipation—Vincristine—colon cancer	7.72e-05	0.00119	CcSEcCtD
Tamoxifen—Flushing—Capecitabine—colon cancer	7.69e-05	0.00119	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Fluorouracil—colon cancer	7.67e-05	0.00118	CcSEcCtD
Tamoxifen—Decreased appetite—Irinotecan—colon cancer	7.64e-05	0.00118	CcSEcCtD
Tamoxifen—Insomnia—Fluorouracil—colon cancer	7.62e-05	0.00118	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Irinotecan—colon cancer	7.59e-05	0.00117	CcSEcCtD
Tamoxifen—Fatigue—Irinotecan—colon cancer	7.58e-05	0.00117	CcSEcCtD
Tamoxifen—Paraesthesia—Fluorouracil—colon cancer	7.56e-05	0.00117	CcSEcCtD
Tamoxifen—Pancreatitis—Methotrexate—colon cancer	7.55e-05	0.00117	CcSEcCtD
Tamoxifen—Constipation—Irinotecan—colon cancer	7.52e-05	0.00116	CcSEcCtD
Tamoxifen—Pain—Irinotecan—colon cancer	7.52e-05	0.00116	CcSEcCtD
Tamoxifen—Dyspnoea—Fluorouracil—colon cancer	7.51e-05	0.00116	CcSEcCtD
Tamoxifen—Clomifene—ABCB1—colon cancer	7.47e-05	0.212	CrCbGaD
Tamoxifen—Dyspepsia—Fluorouracil—colon cancer	7.41e-05	0.00114	CcSEcCtD
Tamoxifen—Arrhythmia—Capecitabine—colon cancer	7.4e-05	0.00114	CcSEcCtD
Tamoxifen—CYP1A1—lymph node—colon cancer	7.39e-05	0.00215	CbGeAlD
Tamoxifen—Abdominal discomfort—Methotrexate—colon cancer	7.39e-05	0.00114	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Vincristine—colon cancer	7.38e-05	0.00114	CcSEcCtD
Tamoxifen—Decreased appetite—Fluorouracil—colon cancer	7.32e-05	0.00113	CcSEcCtD
Tamoxifen—Alopecia—Capecitabine—colon cancer	7.32e-05	0.00113	CcSEcCtD
Tamoxifen—Pancytopenia—Methotrexate—colon cancer	7.32e-05	0.00113	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Fluorouracil—colon cancer	7.27e-05	0.00112	CcSEcCtD
Tamoxifen—Erythema—Capecitabine—colon cancer	7.21e-05	0.00111	CcSEcCtD
Tamoxifen—Neutropenia—Methotrexate—colon cancer	7.2e-05	0.00111	CcSEcCtD
Tamoxifen—Pain—Fluorouracil—colon cancer	7.2e-05	0.00111	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Irinotecan—colon cancer	7.19e-05	0.00111	CcSEcCtD
Tamoxifen—Abdominal pain—Vincristine—colon cancer	7.14e-05	0.0011	CcSEcCtD
Tamoxifen—Erectile dysfunction—Methotrexate—colon cancer	7.1e-05	0.00109	CcSEcCtD
Tamoxifen—CYP3A4—liver—colon cancer	7.07e-05	0.00206	CbGeAlD
Tamoxifen—Dysgeusia—Capecitabine—colon cancer	7.06e-05	0.00109	CcSEcCtD
Tamoxifen—Back pain—Capecitabine—colon cancer	6.98e-05	0.00108	CcSEcCtD
Tamoxifen—CYP2D6—liver—colon cancer	6.96e-05	0.00202	CbGeAlD
Tamoxifen—Abdominal pain—Irinotecan—colon cancer	6.95e-05	0.00107	CcSEcCtD
Tamoxifen—Muscle spasms—Capecitabine—colon cancer	6.93e-05	0.00107	CcSEcCtD
Tamoxifen—Pneumonia—Methotrexate—colon cancer	6.91e-05	0.00107	CcSEcCtD
Tamoxifen—Depression—Methotrexate—colon cancer	6.85e-05	0.00106	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Methotrexate—colon cancer	6.81e-05	0.00105	CcSEcCtD
Tamoxifen—ABCB1—lymphoid tissue—colon cancer	6.8e-05	0.00198	CbGeAlD
Tamoxifen—ABCB1—digestive system—colon cancer	6.72e-05	0.00195	CbGeAlD
Tamoxifen—Urticaria—Fluorouracil—colon cancer	6.69e-05	0.00103	CcSEcCtD
Tamoxifen—Anaemia—Capecitabine—colon cancer	6.66e-05	0.00103	CcSEcCtD
Tamoxifen—Hypersensitivity—Vincristine—colon cancer	6.65e-05	0.00103	CcSEcCtD
Tamoxifen—Sweating—Methotrexate—colon cancer	6.59e-05	0.00102	CcSEcCtD
Tamoxifen—Hypersensitivity—Irinotecan—colon cancer	6.48e-05	0.001	CcSEcCtD
Tamoxifen—Asthenia—Vincristine—colon cancer	6.48e-05	0.001	CcSEcCtD
Tamoxifen—Leukopenia—Capecitabine—colon cancer	6.45e-05	0.000996	CcSEcCtD
Tamoxifen—Asthenia—Irinotecan—colon cancer	6.31e-05	0.000973	CcSEcCtD
Tamoxifen—Cough—Capecitabine—colon cancer	6.29e-05	0.000971	CcSEcCtD
Tamoxifen—Hypertension—Capecitabine—colon cancer	6.23e-05	0.000961	CcSEcCtD
Tamoxifen—Hypersensitivity—Fluorouracil—colon cancer	6.2e-05	0.000957	CcSEcCtD
Tamoxifen—Haemoglobin—Methotrexate—colon cancer	6.2e-05	0.000956	CcSEcCtD
Tamoxifen—ABCB1—bone marrow—colon cancer	6.19e-05	0.0018	CbGeAlD
Tamoxifen—Diarrhoea—Vincristine—colon cancer	6.18e-05	0.000953	CcSEcCtD
Tamoxifen—Haemorrhage—Methotrexate—colon cancer	6.17e-05	0.000952	CcSEcCtD
Tamoxifen—Hepatitis—Methotrexate—colon cancer	6.17e-05	0.000952	CcSEcCtD
Tamoxifen—Myalgia—Capecitabine—colon cancer	6.14e-05	0.000947	CcSEcCtD
Tamoxifen—Chest pain—Capecitabine—colon cancer	6.14e-05	0.000947	CcSEcCtD
Tamoxifen—Arthralgia—Capecitabine—colon cancer	6.14e-05	0.000947	CcSEcCtD
Tamoxifen—Pharyngitis—Methotrexate—colon cancer	6.12e-05	0.000944	CcSEcCtD
Tamoxifen—Anxiety—Capecitabine—colon cancer	6.12e-05	0.000944	CcSEcCtD
Tamoxifen—Discomfort—Capecitabine—colon cancer	6.07e-05	0.000936	CcSEcCtD
Tamoxifen—Diarrhoea—Irinotecan—colon cancer	6.02e-05	0.000928	CcSEcCtD
Tamoxifen—Dry mouth—Capecitabine—colon cancer	6e-05	0.000926	CcSEcCtD
Tamoxifen—Dizziness—Vincristine—colon cancer	5.97e-05	0.000921	CcSEcCtD
Tamoxifen—Pruritus—Fluorouracil—colon cancer	5.96e-05	0.000919	CcSEcCtD
Tamoxifen—Visual impairment—Methotrexate—colon cancer	5.94e-05	0.000917	CcSEcCtD
Tamoxifen—ABCB1—vagina—colon cancer	5.93e-05	0.00173	CbGeAlD
Tamoxifen—Oedema—Capecitabine—colon cancer	5.89e-05	0.000908	CcSEcCtD
Tamoxifen—Infection—Capecitabine—colon cancer	5.85e-05	0.000902	CcSEcCtD
Tamoxifen—Erythema multiforme—Methotrexate—colon cancer	5.83e-05	0.0009	CcSEcCtD
Tamoxifen—Dizziness—Irinotecan—colon cancer	5.81e-05	0.000897	CcSEcCtD
Tamoxifen—Diarrhoea—Fluorouracil—colon cancer	5.76e-05	0.000889	CcSEcCtD
Tamoxifen—Thrombocytopenia—Capecitabine—colon cancer	5.76e-05	0.000889	CcSEcCtD
Tamoxifen—Vomiting—Vincristine—colon cancer	5.74e-05	0.000886	CcSEcCtD
Tamoxifen—Rash—Vincristine—colon cancer	5.69e-05	0.000878	CcSEcCtD
Tamoxifen—Hyperhidrosis—Capecitabine—colon cancer	5.69e-05	0.000878	CcSEcCtD
Tamoxifen—Dermatitis—Vincristine—colon cancer	5.69e-05	0.000878	CcSEcCtD
Tamoxifen—Headache—Vincristine—colon cancer	5.66e-05	0.000873	CcSEcCtD
Tamoxifen—Anorexia—Capecitabine—colon cancer	5.61e-05	0.000866	CcSEcCtD
Tamoxifen—Vomiting—Irinotecan—colon cancer	5.59e-05	0.000863	CcSEcCtD
Tamoxifen—Dizziness—Fluorouracil—colon cancer	5.57e-05	0.000859	CcSEcCtD
Tamoxifen—Rash—Irinotecan—colon cancer	5.54e-05	0.000855	CcSEcCtD
Tamoxifen—Dermatitis—Irinotecan—colon cancer	5.54e-05	0.000855	CcSEcCtD
Tamoxifen—Headache—Irinotecan—colon cancer	5.51e-05	0.00085	CcSEcCtD
Tamoxifen—Alopecia—Methotrexate—colon cancer	5.45e-05	0.000841	CcSEcCtD
Tamoxifen—Erythema—Methotrexate—colon cancer	5.37e-05	0.000828	CcSEcCtD
Tamoxifen—Nausea—Vincristine—colon cancer	5.36e-05	0.000828	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Capecitabine—colon cancer	5.36e-05	0.000827	CcSEcCtD
Tamoxifen—Vomiting—Fluorouracil—colon cancer	5.35e-05	0.000826	CcSEcCtD
Tamoxifen—Insomnia—Capecitabine—colon cancer	5.32e-05	0.000821	CcSEcCtD
Tamoxifen—Rash—Fluorouracil—colon cancer	5.31e-05	0.000819	CcSEcCtD
Tamoxifen—Dermatitis—Fluorouracil—colon cancer	5.31e-05	0.000819	CcSEcCtD
Tamoxifen—Paraesthesia—Capecitabine—colon cancer	5.28e-05	0.000815	CcSEcCtD
Tamoxifen—Headache—Fluorouracil—colon cancer	5.28e-05	0.000814	CcSEcCtD
Tamoxifen—Dysgeusia—Methotrexate—colon cancer	5.26e-05	0.000811	CcSEcCtD
Tamoxifen—Dyspnoea—Capecitabine—colon cancer	5.25e-05	0.00081	CcSEcCtD
Tamoxifen—Nausea—Irinotecan—colon cancer	5.22e-05	0.000806	CcSEcCtD
Tamoxifen—Back pain—Methotrexate—colon cancer	5.19e-05	0.000801	CcSEcCtD
Tamoxifen—Dyspepsia—Capecitabine—colon cancer	5.18e-05	0.000799	CcSEcCtD
Tamoxifen—Decreased appetite—Capecitabine—colon cancer	5.12e-05	0.000789	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Capecitabine—colon cancer	5.08e-05	0.000784	CcSEcCtD
Tamoxifen—Fatigue—Capecitabine—colon cancer	5.07e-05	0.000783	CcSEcCtD
Tamoxifen—Constipation—Capecitabine—colon cancer	5.03e-05	0.000777	CcSEcCtD
Tamoxifen—Pain—Capecitabine—colon cancer	5.03e-05	0.000777	CcSEcCtD
Tamoxifen—ABCB1—liver—colon cancer	5e-05	0.00146	CbGeAlD
Tamoxifen—Nausea—Fluorouracil—colon cancer	5e-05	0.000772	CcSEcCtD
Tamoxifen—Anaemia—Methotrexate—colon cancer	4.96e-05	0.000766	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Capecitabine—colon cancer	4.81e-05	0.000743	CcSEcCtD
Tamoxifen—Loperamide—ABCB1—colon cancer	4.81e-05	0.136	CrCbGaD
Tamoxifen—Leukopenia—Methotrexate—colon cancer	4.81e-05	0.000741	CcSEcCtD
Tamoxifen—Cough—Methotrexate—colon cancer	4.68e-05	0.000723	CcSEcCtD
Tamoxifen—Urticaria—Capecitabine—colon cancer	4.68e-05	0.000721	CcSEcCtD
Tamoxifen—Abdominal pain—Capecitabine—colon cancer	4.65e-05	0.000718	CcSEcCtD
Tamoxifen—Chest pain—Methotrexate—colon cancer	4.57e-05	0.000705	CcSEcCtD
Tamoxifen—Myalgia—Methotrexate—colon cancer	4.57e-05	0.000705	CcSEcCtD
Tamoxifen—Arthralgia—Methotrexate—colon cancer	4.57e-05	0.000705	CcSEcCtD
Tamoxifen—Discomfort—Methotrexate—colon cancer	4.52e-05	0.000697	CcSEcCtD
Tamoxifen—Infection—Methotrexate—colon cancer	4.35e-05	0.000672	CcSEcCtD
Tamoxifen—Hypersensitivity—Capecitabine—colon cancer	4.34e-05	0.000669	CcSEcCtD
Tamoxifen—Thrombocytopenia—Methotrexate—colon cancer	4.29e-05	0.000662	CcSEcCtD
Tamoxifen—Hyperhidrosis—Methotrexate—colon cancer	4.24e-05	0.000654	CcSEcCtD
Tamoxifen—Asthenia—Capecitabine—colon cancer	4.22e-05	0.000652	CcSEcCtD
Tamoxifen—Anorexia—Methotrexate—colon cancer	4.18e-05	0.000644	CcSEcCtD
Tamoxifen—Pruritus—Capecitabine—colon cancer	4.16e-05	0.000642	CcSEcCtD
Tamoxifen—Diarrhoea—Capecitabine—colon cancer	4.03e-05	0.000621	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Methotrexate—colon cancer	3.99e-05	0.000616	CcSEcCtD
Tamoxifen—Insomnia—Methotrexate—colon cancer	3.96e-05	0.000611	CcSEcCtD
Tamoxifen—Paraesthesia—Methotrexate—colon cancer	3.93e-05	0.000607	CcSEcCtD
Tamoxifen—Dyspnoea—Methotrexate—colon cancer	3.91e-05	0.000603	CcSEcCtD
Tamoxifen—Dizziness—Capecitabine—colon cancer	3.89e-05	0.000601	CcSEcCtD
Tamoxifen—Dyspepsia—Methotrexate—colon cancer	3.86e-05	0.000595	CcSEcCtD
Tamoxifen—ABCB1—lymph node—colon cancer	3.84e-05	0.00112	CbGeAlD
Tamoxifen—Decreased appetite—Methotrexate—colon cancer	3.81e-05	0.000588	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Methotrexate—colon cancer	3.78e-05	0.000584	CcSEcCtD
Tamoxifen—Fatigue—Methotrexate—colon cancer	3.78e-05	0.000583	CcSEcCtD
Tamoxifen—Pain—Methotrexate—colon cancer	3.75e-05	0.000578	CcSEcCtD
Tamoxifen—Vomiting—Capecitabine—colon cancer	3.74e-05	0.000577	CcSEcCtD
Tamoxifen—Rash—Capecitabine—colon cancer	3.71e-05	0.000573	CcSEcCtD
Tamoxifen—Dermatitis—Capecitabine—colon cancer	3.71e-05	0.000572	CcSEcCtD
Tamoxifen—Headache—Capecitabine—colon cancer	3.69e-05	0.000569	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Methotrexate—colon cancer	3.58e-05	0.000553	CcSEcCtD
Tamoxifen—Nausea—Capecitabine—colon cancer	3.5e-05	0.000539	CcSEcCtD
Tamoxifen—Urticaria—Methotrexate—colon cancer	3.48e-05	0.000537	CcSEcCtD
Tamoxifen—Abdominal pain—Methotrexate—colon cancer	3.46e-05	0.000534	CcSEcCtD
Tamoxifen—Methadone—ABCB1—colon cancer	3.42e-05	0.0971	CrCbGaD
Tamoxifen—Hypersensitivity—Methotrexate—colon cancer	3.23e-05	0.000498	CcSEcCtD
Tamoxifen—Asthenia—Methotrexate—colon cancer	3.14e-05	0.000485	CcSEcCtD
Tamoxifen—Pruritus—Methotrexate—colon cancer	3.1e-05	0.000478	CcSEcCtD
Tamoxifen—Diarrhoea—Methotrexate—colon cancer	3e-05	0.000463	CcSEcCtD
Tamoxifen—Dizziness—Methotrexate—colon cancer	2.9e-05	0.000447	CcSEcCtD
Tamoxifen—Vomiting—Methotrexate—colon cancer	2.79e-05	0.00043	CcSEcCtD
Tamoxifen—Rash—Methotrexate—colon cancer	2.76e-05	0.000426	CcSEcCtD
Tamoxifen—Dermatitis—Methotrexate—colon cancer	2.76e-05	0.000426	CcSEcCtD
Tamoxifen—Headache—Methotrexate—colon cancer	2.74e-05	0.000423	CcSEcCtD
Tamoxifen—Nausea—Methotrexate—colon cancer	2.6e-05	0.000402	CcSEcCtD
Tamoxifen—ESR2—Generic Transcription Pathway—MYC—colon cancer	1.1e-05	0.000342	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.09e-05	0.000341	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.09e-05	0.00034	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—HNF4A—colon cancer	1.08e-05	0.000336	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CHST5—colon cancer	1.07e-05	0.000334	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ODC1—colon cancer	1.07e-05	0.000334	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.07e-05	0.000334	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CA7—colon cancer	1.06e-05	0.000332	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—HRAS—colon cancer	1.05e-05	0.000328	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ABCB1—colon cancer	1.05e-05	0.000327	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ODC1—colon cancer	1.04e-05	0.000326	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CHST5—colon cancer	1.04e-05	0.000326	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—AKT1—colon cancer	1.04e-05	0.000325	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—TYMS—colon cancer	1.03e-05	0.000321	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.03e-05	0.000321	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CHST5—colon cancer	9.85e-06	0.000308	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ODC1—colon cancer	9.85e-06	0.000308	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—EP300—colon cancer	9.77e-06	0.000305	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ODC1—colon cancer	9.76e-06	0.000305	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CHST5—colon cancer	9.76e-06	0.000305	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—PPARG—colon cancer	9.7e-06	0.000303	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—EP300—colon cancer	9.59e-06	0.000299	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—PTGS2—colon cancer	9.57e-06	0.000299	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	9.56e-06	0.000298	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.49e-06	0.000297	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	9.45e-06	0.000295	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—AKT1—colon cancer	9.31e-06	0.000291	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—AKT1—colon cancer	9.27e-06	0.000289	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—PPARG—colon cancer	9.26e-06	0.000289	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—EP300—colon cancer	9.26e-06	0.000289	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	9.14e-06	0.000285	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.11e-06	0.000284	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—PTGS2—colon cancer	8.9e-06	0.000278	CbGpPWpGaD
Tamoxifen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	8.87e-06	0.000277	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.77e-06	0.000274	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PPARG—colon cancer	8.7e-06	0.000272	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CHST5—colon cancer	8.34e-06	0.000261	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ODC1—colon cancer	8.34e-06	0.000261	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—MYC—colon cancer	8.3e-06	0.000259	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	8.13e-06	0.000254	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—EP300—colon cancer	7.96e-06	0.000249	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.9e-06	0.000247	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ABCB1—colon cancer	7.73e-06	0.000241	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	7.72e-06	0.000241	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—TYMS—colon cancer	7.59e-06	0.000237	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	7.54e-06	0.000236	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—EP300—colon cancer	7.4e-06	0.000231	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	7.34e-06	0.000229	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PPARG—colon cancer	7.29e-06	0.000228	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	7.27e-06	0.000227	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—PIK3CA—colon cancer	7.23e-06	0.000226	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.16e-06	0.000224	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	7.1e-06	0.000222	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—PIK3CA—colon cancer	7.09e-06	0.000222	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.9e-06	0.000215	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—PIK3CA—colon cancer	6.85e-06	0.000214	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PTGS2—colon cancer	6.84e-06	0.000214	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	6.76e-06	0.000211	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	6.57e-06	0.000205	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CHST5—colon cancer	6.44e-06	0.000201	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ODC1—colon cancer	6.44e-06	0.000201	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	6.4e-06	0.0002	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.96e-06	0.000186	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—AKT1—colon cancer	5.9e-06	0.000184	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—PIK3CA—colon cancer	5.89e-06	0.000184	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.89e-06	0.000184	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.87e-06	0.000183	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.84e-06	0.000182	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ABCB1—colon cancer	5.83e-06	0.000182	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—AKT1—colon cancer	5.79e-06	0.000181	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	5.76e-06	0.00018	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—AKT1—colon cancer	5.75e-06	0.00018	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.74e-06	0.000179	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PTGS2—colon cancer	5.74e-06	0.000179	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—TYMS—colon cancer	5.72e-06	0.000179	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—EP300—colon cancer	5.69e-06	0.000178	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ABCB1—colon cancer	5.61e-06	0.000175	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—AKT1—colon cancer	5.6e-06	0.000175	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—MYC—colon cancer	5.53e-06	0.000173	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—TYMS—colon cancer	5.51e-06	0.000172	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—PIK3CA—colon cancer	5.48e-06	0.000171	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	5.44e-06	0.00017	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.4e-06	0.000169	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PPARG—colon cancer	5.37e-06	0.000168	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—MYC—colon cancer	5.28e-06	0.000165	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ABCB1—colon cancer	5.11e-06	0.00016	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ABCB1—colon cancer	5.06e-06	0.000158	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—TYMS—colon cancer	5.02e-06	0.000157	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	5e-06	0.000156	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—TYMS—colon cancer	4.97e-06	0.000155	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.95e-06	0.000155	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.84e-06	0.000151	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—AKT1—colon cancer	4.81e-06	0.00015	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—EP300—colon cancer	4.77e-06	0.000149	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—PPARG—colon cancer	4.67e-06	0.000146	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ABCB1—colon cancer	4.64e-06	0.000145	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—TYMS—colon cancer	4.56e-06	0.000142	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—AKT1—colon cancer	4.47e-06	0.00014	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.42e-06	0.000138	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.41e-06	0.000138	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.25e-06	0.000133	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.24e-06	0.000133	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTGS2—colon cancer	4.23e-06	0.000132	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PIK3CA—colon cancer	4.21e-06	0.000132	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	4.08e-06	0.000128	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PPARG—colon cancer	4.06e-06	0.000127	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.03e-06	0.000126	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PPARG—colon cancer	3.91e-06	0.000122	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.89e-06	0.000122	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ABCB1—colon cancer	3.74e-06	0.000117	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—TYMS—colon cancer	3.68e-06	0.000115	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ABCB1—colon cancer	3.67e-06	0.000115	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—AKT1—colon cancer	3.66e-06	0.000114	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ABCB1—colon cancer	3.66e-06	0.000114	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—TYMS—colon cancer	3.6e-06	0.000112	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—TYMS—colon cancer	3.59e-06	0.000112	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PPARG—colon cancer	3.55e-06	0.000111	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.53e-06	0.00011	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PIK3CA—colon cancer	3.53e-06	0.00011	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PPARG—colon cancer	3.52e-06	0.00011	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—EP300—colon cancer	3.52e-06	0.00011	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.48e-06	0.000109	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ABCB1—colon cancer	3.46e-06	0.000108	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.44e-06	0.000108	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—AKT1—colon cancer	3.44e-06	0.000107	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGFR3—colon cancer	3.43e-06	0.000107	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—TYMS—colon cancer	3.39e-06	0.000106	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.24e-06	0.000101	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PPARG—colon cancer	3.23e-06	0.000101	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—colon cancer	3.19e-06	9.96e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.17e-06	9.9e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ABCB1—colon cancer	3.17e-06	9.9e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—APC—colon cancer	3.15e-06	9.82e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—TYMS—colon cancer	3.11e-06	9.72e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—colon cancer	3.07e-06	9.6e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—BRAF—colon cancer	2.96e-06	9.23e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.89e-06	9.03e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AKT1—colon cancer	2.88e-06	9e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ABCB1—colon cancer	2.83e-06	8.84e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—colon cancer	2.79e-06	8.73e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—TYMS—colon cancer	2.78e-06	8.68e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—colon cancer	2.77e-06	8.65e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—TYMS—colon cancer	2.71e-06	8.47e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.71e-06	8.46e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—colon cancer	2.66e-06	8.31e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—EP300—colon cancer	2.65e-06	8.29e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.64e-06	8.23e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.61e-06	8.16e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PPARG—colon cancer	2.6e-06	8.13e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ABCB1—colon cancer	2.6e-06	8.13e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PIK3CA—colon cancer	2.6e-06	8.12e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ABCB1—colon cancer	2.58e-06	8.06e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—TYMS—colon cancer	2.56e-06	7.98e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—EP300—colon cancer	2.55e-06	7.98e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PPARG—colon cancer	2.55e-06	7.97e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PPARG—colon cancer	2.55e-06	7.95e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—colon cancer	2.54e-06	7.93e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—TYMS—colon cancer	2.53e-06	7.91e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARG—colon cancer	2.4e-06	7.51e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.4e-06	7.48e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—EP300—colon cancer	2.32e-06	7.26e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—EP300—colon cancer	2.3e-06	7.2e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.25e-06	7.04e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—colon cancer	2.22e-06	6.92e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARG—colon cancer	2.2e-06	6.89e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ABCB1—colon cancer	2.2e-06	6.88e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—TYMS—colon cancer	2.16e-06	6.76e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCND1—colon cancer	2.16e-06	6.74e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.14e-06	6.68e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CTNNB1—colon cancer	2.14e-06	6.67e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—colon cancer	2.13e-06	6.64e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—EP300—colon cancer	2.11e-06	6.6e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN1A—colon cancer	2.09e-06	6.52e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—colon cancer	2.05e-06	6.4e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—colon cancer	2.01e-06	6.27e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—colon cancer	2e-06	6.25e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EP300—colon cancer	1.99e-06	6.2e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARG—colon cancer	1.97e-06	6.15e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CA—colon cancer	1.96e-06	6.13e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.95e-06	6.09e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SRC—colon cancer	1.93e-06	6.03e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARG—colon cancer	1.92e-06	6e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—colon cancer	1.89e-06	5.91e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CA—colon cancer	1.89e-06	5.9e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—colon cancer	1.88e-06	5.88e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NRAS—colon cancer	1.86e-06	5.8e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—colon cancer	1.85e-06	5.77e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARG—colon cancer	1.81e-06	5.65e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARG—colon cancer	1.79e-06	5.6e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—colon cancer	1.73e-06	5.42e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—colon cancer	1.73e-06	5.41e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—colon cancer	1.73e-06	5.39e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CA—colon cancer	1.72e-06	5.37e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CA—colon cancer	1.7e-06	5.32e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—EP300—colon cancer	1.7e-06	5.32e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCB1—colon cancer	1.7e-06	5.31e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—colon cancer	1.69e-06	5.29e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TYMS—colon cancer	1.67e-06	5.22e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—EP300—colon cancer	1.67e-06	5.21e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.67e-06	5.21e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—EP300—colon cancer	1.67e-06	5.2e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—colon cancer	1.6e-06	5.01e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—colon cancer	1.6e-06	5e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—EP300—colon cancer	1.57e-06	4.91e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CA—colon cancer	1.56e-06	4.88e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—colon cancer	1.55e-06	4.84e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—colon cancer	1.54e-06	4.82e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARG—colon cancer	1.53e-06	4.79e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—colon cancer	1.51e-06	4.72e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CA—colon cancer	1.47e-06	4.59e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—EP300—colon cancer	1.44e-06	4.51e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—colon cancer	1.42e-06	4.45e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—colon cancer	1.42e-06	4.44e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—colon cancer	1.41e-06	4.41e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—colon cancer	1.4e-06	4.39e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—colon cancer	1.39e-06	4.35e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRAS—colon cancer	1.36e-06	4.25e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—EP300—colon cancer	1.29e-06	4.02e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—colon cancer	1.28e-06	3.99e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CA—colon cancer	1.26e-06	3.94e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—EP300—colon cancer	1.26e-06	3.93e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CA—colon cancer	1.23e-06	3.86e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CA—colon cancer	1.23e-06	3.85e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—colon cancer	1.21e-06	3.77e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—colon cancer	1.2e-06	3.75e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—EP300—colon cancer	1.18e-06	3.7e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARG—colon cancer	1.18e-06	3.7e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—EP300—colon cancer	1.17e-06	3.67e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CA—colon cancer	1.16e-06	3.64e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CA—colon cancer	1.07e-06	3.33e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—colon cancer	1.03e-06	3.22e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—colon cancer	1.01e-06	3.15e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—colon cancer	1.01e-06	3.14e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—EP300—colon cancer	1e-06	3.13e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CA—colon cancer	9.52e-07	2.98e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—colon cancer	9.51e-07	2.97e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—colon cancer	9.31e-07	2.91e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CA—colon cancer	9.3e-07	2.9e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CA—colon cancer	8.76e-07	2.74e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—colon cancer	8.72e-07	2.72e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CA—colon cancer	8.68e-07	2.71e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—colon cancer	7.78e-07	2.43e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—EP300—colon cancer	7.74e-07	2.42e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—colon cancer	7.59e-07	2.37e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CA—colon cancer	7.42e-07	2.32e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—colon cancer	7.16e-07	2.24e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—colon cancer	7.09e-07	2.22e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—colon cancer	6.06e-07	1.89e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CA—colon cancer	5.73e-07	1.79e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—colon cancer	4.68e-07	1.46e-05	CbGpPWpGaD
